![](/coreweb/template1/pix/main_left_bg.gif) |
![](/coreweb/template1/pix/pixel.gif) |
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Dec 01, 2023 |
Title |
HDF_untreated_YAP_Rep2 |
Sample type |
SRA |
|
|
Source name |
HDF
|
Organism |
Homo sapiens |
Characteristics |
cell type: Dermal fibroblast (LONZA CC-2511) passage: Passage 9 treatment: control chip antibody: anti-YAP: ab52771 (Abcam), Research Resource Identifier: AB_2219141
|
Treatment protocol |
Starvation and experiments were performed in DMEM containing 50 U/L penicillin/streptomycin, 0.5% FBS and 17 mM ascorbic acid (A8960; Sigma-Aldrich). Human dermal fibroblasts (15,000/cm2) were serum starved for 16 hours and subsequently exposed to TGFβ1 for 24 hours.
|
Growth protocol |
Primary human dermal fibroblasts (CC-2511; Lonza, Basel, Switzerland) were sub-cultured in Dulbecco’s modified Eagle medium (DMEM, 12-604F; Lonza) containing 50 U/L penicillin/streptomycin (15140122; Thermo Scientific) and 10% fetal bovine serum (FBS; Sigma-Aldrich). Before commencing experiments, cells were verified to be mycoplasm free.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Protein complexes were cross-linked with 1.5 mM ethylene glycol bis(succinimidyl succinate) (21565; Thermo Scientific) in PBS with gentle agitation at RT for 15 minutes. Cross-linking of protein complexes to DNA was performed by adding methanol-free formaldehyde to a final concentration of 1% and incubation with gentle agitation at RT for 8 minutes. Next, cross-linking was quenched by adding glycine to a final concentration of 200 mM at RT for 5 minutes. Cells were then washed three times with ice-cold PBS containing 1% protease inhibitor cocktail, collected by scraping, and pelleted by centrifugation at 2000 × g for 5 minutes at 4°C. Nuclei were purified by re-suspending pellets in buffer LB1 (50 mM Hepes-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100, 1% protease inhibitor cocktail) and washed in buffer LB2 (10 mM Tris HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% protease inhibitor cocktail) followed by lysis in buffer LB3 (10 mM Tris HCl p.H 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-deoxycholate, 0.5% N-lauroylsarcosine, 1% NP-40, 1% Triton X-100, 1% protease inhibitor cocktail) while rotating for 1 hour at 4°C. Chromatin samples were sheared twice using a BioRuptor PLUS device (B01020001; Diagenode, Liège, Belgium) for 6 minutes at 4°C. Correct chromatin fragment size was verified using gel electrophoresis. Dynabeads (10002D; Thermo Fisher Scientific) were incubated for 4 hours with primary antibodies. YAP bound chromatin was precipitated in RIPA buffer (50 mM HEPES pH 7.6, 1 mM EDTA, 0.7% Na deoxycholate, 1% NP-40, 0.5 M LiCL, 1% protease inhibitor cocktail) at 4°C on a rotating platform for 18 hours. Afterwards the beads were washed five times in RIPA buffer, and once with TE buffer (10 mM Tris, 1mM EDTA, pH 8.0). Immunoprecipitated chromatin was eluted with elution buffer (1% SDS, 0.1M NaHCO3), de-crosslinked overnight, and cleaned up using RNAse and Protease-K treatment, followed by purification with a PCR cleanup kit (Qiagen). Sequencing libraries were prepared for input control and two biological replicates for YAP in each culture condition using the NEBNext Ultra II DNA Library Prep Kit according to manufacturer's instructions (E7370; New England Biolabs, USA). Library quality was verified using BioAnalzyer.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
NextSeq 550 |
|
|
Data processing |
For Chip-seq, reads were aligned to the human genome build hg19 using BWA (v0.7.12) with default settings. PCR duplicates and unmapped reads were removed with SAMTools (v0.1.19). Normalized peak coverage files (bigwig) as reads per genomic content, were generated with DeepTools bamCoverage (2.5.1) with 10bp bins from merged (SamTools) with the following parameters: --normalizeTo1x 2451960000 --extendReads 200 -bs 10 --ignoreDuplicates --bl. Blacklisted regions (downloaded from ENCODE) were excluded. Genome_build: hg19 Supplementary_files_format_and_content: bigwig from merged YAP Chip-seq sample replicates and input DNA
|
|
|
Submission date |
Dec 26, 2017 |
Last update date |
Dec 01, 2023 |
Contact name |
Bram Piersma |
E-mail(s) |
brampiersma@gmail.com
|
Organization name |
University Medical Center Groningen
|
Department |
Pathology and Medical Biology
|
Street address |
Hanzeplein 1
|
City |
Groningen |
State/province |
Groningen |
ZIP/Postal code |
9713GZ |
Country |
Netherlands |
|
|
Platform ID |
GPL21697 |
Series (1) |
GSE108516 |
Targeting of the YAP/SMAD molecular circuit inhibits a TGFb1-induced myofibroblast phenotype |
|
Relations |
BioSample |
SAMN08243176 |
SRA |
SRX3511910 |
Supplementary data files not provided |
SRA Run Selector![Help](/coreweb/images/long_help4.gif) |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
![](/coreweb/template1/pix/main_right_bg.gif) |